Related Experiment Video

Updated: Dec 30, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.1K

Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer

Kei Kudo1,2, Miyuki Nomura1, Yoshimi Sakamoto1

  • 1Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.

FEBS Letters
|January 18, 2020
PubMed

Insights

Targeting cancer metabolism is crucial for ovarian cancer (OVC) treatment. Researchers found that ovarian cancer cells vary in their reliance on nicotinamide phosphoribosyltransferase (NAMPT) for glycolysis, impacting treatment response.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Biochemistry

Background:

  • Targeting cancer metabolism is a key strategy for treating malignancies like ovarian cancer (OVC).
  • Nicotinamide phosphoribosyltransferase (NAMPT), an enzyme in NAD salvage, is a potential therapeutic target in OVC.
  • Understanding patient responsiveness to NAMPT inhibition is critical for effective treatment.

Purpose of the Study:

  • To investigate the role of NAMPT in ovarian cancer glycolysis.
  • To determine factors influencing OVC cell sensitivity to NAMPT inhibition.
  • To identify patient subgroups that may benefit from NAMPT-targeting therapies.

Main Methods:

  • Categorization of OVC cell lines based on NAMPT dependency in glycolysis.
  • Analysis of metabolic profiles and correlation with drug sensitivity.
  • Investigation of BRCA1/2 mutation status in relation to metabolic subgroups.

Main Results:

  • OVC cell lines were classified into NAMPT-dependent and NAMPT-independent glycolytic subgroups.
  • Metabolic differences correlated with varying vulnerability to NAMPT inhibition.
  • NAMPT-dependent cells were more prevalent in OVC lacking BRCA1/2 mutations.

Conclusions:

  • OVC exhibits distinct metabolic phenotypes influencing response to NAMPT inhibitors.
  • Patient selection based on metabolic profiles and BRCA1/2 status may optimize NAMPT-targeting therapy efficacy.
  • This research highlights the importance of personalized medicine in ovarian cancer treatment.
Keywords:
BRCANADNAMPTcancer metabolismmetabolismovarian cancer

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.7K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.1K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K